LFCR Q1 2025 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$267M

Q1 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$25M+0.7% YoY

Gross Profit

$5M21.8% margin

Operating Income

-$12M-46.9% margin

Net Income

-$16M-65.7% margin

EPS (Diluted)

$-0.53

QoQ Revenue Growth

-34.8%

Cash Flow

Operating Cash Flow

-$643,000

Free Cash Flow

-$4M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$247M

Total Liabilities

$251M

Stockholders' Equity

-$4M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$25M	$25M	+0.7%
Gross Profit	$5M	$3M	+97.5%
Operating Income	-$12M	-$9M	-34.5%
Net Income	-$16M	-$11M	-50.9%